tiprankstipranks
Theravance Biopharma (TBPH)
NASDAQ:TBPH
US Market
TBPH
Theravance Biopharma
RESEARCH TOOLSreports
Want to see TBPH full AI Analyst Report?

Theravance Biopharma (TBPH) Ratios

352 Followers

Theravance Biopharma Ratios

TBPH's free cash flow for Q2 2026 was $0.93. For the 2026 fiscal year, TBPH's free cash flow was decreased by $ and operating cash flow was $-0.03. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 13.54 10.93 5.02 5.39 12.31
Quick Ratio
 13.54 10.93 5.02 5.39 12.31
Cash Ratio
 7.14 4.38 1.18 1.60 10.38
Solvency Ratio
 0.32 0.59 -0.30 -0.31 5.28
Operating Cash Flow Ratio
 1.68 6.23 -0.36 -1.09 -6.51
Short-Term Operating Cash Flow Coverage
 0.00 21.79 0.00 0.00 0.00
Net Current Asset Value
$ 236.60M$ 229.61M$ -17.55M$ -35.46M$ 187.86M
Leverage Ratios
Debt-to-Assets Ratio
 0.08 0.16 0.14 0.13 0.09
Debt-to-Equity Ratio
 0.13 0.25 0.28 0.23 0.12
Debt-to-Capital Ratio
 0.12 0.20 0.22 0.19 0.11
Long-Term Debt-to-Capital Ratio
 0.00 0.10 0.00 0.00 0.00
Financial Leverage Ratio
 1.62 1.64 2.02 1.79 1.37
Debt Service Coverage Ratio
 54.80 8.49 -19.74 -24.50 -11.95
Interest Coverage Ratio
 4.03 -5.38 -18.44 -23.84 -14.44
Debt to Market Cap
 0.00 0.05 0.00 0.00 0.00
Interest Debt Per Share
 0.77 1.55 1.07 0.93 0.80
Net Debt to EBITDA
 -2.65 -0.67 -0.31 -0.19 3.23
Profitability Margins
Gross Profit Margin
89.40%94.87%41.53%29.26%-23.46%
EBIT Margin
61.61%122.56%-65.34%-93.43%-154.09%
EBITDA Margin
65.63%127.69%-59.73%-89.94%-148.18%
Operating Profit Margin
4.46%-12.33%-72.92%-97.58%-179.09%
Pretax Profit Margin
56.48%120.27%-69.30%-85.80%-180.76%
Net Profit Margin
51.58%98.54%-87.63%-96.11%1698.54%
Continuous Operations Profit Margin
51.58%98.54%-87.63%-96.11%-180.78%
Net Income Per EBT
91.33%81.93%126.46%112.02%-939.65%
EBT Per EBIT
1265.44%-975.74%95.03%87.93%100.93%
Return on Assets (ROA)
11.45%21.81%-15.93%-14.45%143.58%
Return on Equity (ROE)
19.40%35.69%-32.14%-25.91%197.40%
Return on Capital Employed (ROCE)
1.06%-2.96%-14.58%-15.69%-15.89%
Return on Invested Capital (ROIC)
0.95%-2.37%-14.11%-15.52%-15.71%
Return on Tangible Assets
11.45%21.81%-15.93%-14.45%143.58%
Earnings Yield
6.12%11.25%-12.27%-8.88%105.62%
Efficiency Ratios
Receivables Turnover
 5.12 1.12 0.94 3.29 3.06
Payables Turnover
 16.96 2.15 16.79 26.65 40.79
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 3.85 3.55 1.80 1.27 0.99
Asset Turnover
 0.22 0.22 0.18 0.15 0.08
Working Capital Turnover Ratio
 0.27 0.42 0.54 0.26 0.20
Cash Conversion Cycle
 49.80 154.54 366.27 97.37 110.37
Days of Sales Outstanding
 71.32 324.50 388.01 111.07 119.32
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 21.52 169.96 21.74 13.69 8.95
Operating Cycle
 71.32 324.50 388.01 111.07 119.32
Cash Flow Ratios
Operating Cash Flow Per Share
 1.00 4.74 -0.24 -0.49 -2.54
Free Cash Flow Per Share
 1.00 4.74 -0.24 -0.53 -2.55
CapEx Per Share
 <0.01 <0.01 <0.01 0.04 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.03 1.09 1.00
Dividend Paid and CapEx Coverage Ratio
 6.48K 5.68K -34.74 -10.85 -326.91
Capital Expenditure Coverage Ratio
 6.48K 5.68K -34.74 -10.85 -326.91
Operating Cash Flow Coverage Ratio
 1.34 3.16 -0.23 -0.55 -3.58
Operating Cash Flow to Sales Ratio
 0.50 2.22 -0.18 -0.47 -3.64
Free Cash Flow Yield
5.88%25.33%-2.58%-4.74%-22.72%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 15.99 8.91 -8.18 -11.26 0.95
Price-to-Sales (P/S) Ratio
 8.45 8.76 7.14 10.82 16.08
Price-to-Book (P/B) Ratio
 3.03 3.17 2.62 2.92 1.87
Price-to-Free Cash Flow (P/FCF) Ratio
 17.01 3.95 -38.73 -21.08 -4.40
Price-to-Operating Cash Flow Ratio
 16.96 3.95 -39.85 -23.02 -4.42
Price-to-Earnings Growth (PEG) Ratio
 0.05 -0.03 -0.55 0.55 -0.02
Price-to-Fair Value
 3.03 3.17 2.62 2.92 1.87
Enterprise Value Multiple
 10.23 6.19 -12.27 -12.22 -7.62
Enterprise Value
 700.40M 849.12M 471.67M 631.22M 579.68M
EV to EBITDA
 10.23 6.19 -12.27 -12.22 -7.62
EV to Sales
 6.71 7.90 7.33 10.99 11.29
EV to Free Cash Flow
 13.52 3.56 -39.75 -21.41 -3.09
EV to Operating Cash Flow
 13.51 3.56 -40.89 -23.38 -3.10
Tangible Book Value Per Share
 5.61 5.90 3.59 3.85 6.00
Shareholders’ Equity Per Share
 5.61 5.90 3.59 3.85 6.00
Tax and Other Ratios
Effective Tax Rate
 0.09 0.18 -0.26 -0.12 >-0.01
Revenue Per Share
 2.02 2.14 1.32 1.04 0.70
Net Income Per Share
 1.04 2.10 -1.15 -1.00 11.85
Tax Burden
 0.91 0.82 1.26 1.12 -9.40
Interest Burden
 0.92 0.98 1.06 0.92 1.17
Research & Development to Revenue
 0.25 0.35 0.59 0.81 1.36
SG&A to Revenue
 0.50 0.69 1.07 1.14 1.15
Stock-Based Compensation to Revenue
 0.19 0.17 0.33 0.44 0.77
Income Quality
 0.96 2.25 0.20 0.49 2.01
Currency in USD